For the ninth year in a row, “Coach to Cure MD” and Parent Project Muscular Dystrophy (PPMD) will mark Duchenne…
Articles by Margarida Azevedo, MSc
The agency that plays the key role in European Union therapy authorizations has recommended against approval of Raxone (idebenone) as a …
PTC Therapeutics recently announced the recipients of the 2017 global Strategies to Realize Innovation, Vision and Empowerment (STRIVE) Awards…
Parent Project Muscular Dystrophy is holding an awareness, fund-raising and educational campaign throughout September to fight Duchenne muscular dystrophy…
The American Heart Association (AHA) has awarded its distinguished Scientist Development Grant to a University at Albany researcher for…
Continuing an 11-year tradition, the Muscular Dystrophy Association (MDA) will once again team up with Casey’s General Stores in Iowa…
The U.S. Food and Drug Administration (FDA) has granted Capricor Therapeutics rare pediatric disease designation for CAP-1002, its candidate therapy…
Parent Project Muscular Dystrophy (PPMD), a nonprofit working to end Duchenne muscular dystrophy (DMD), has recognized Gillette Children’s…
We know dealing with muscular dystrophy sometimes feels like an uphill battle, both for the patients and the caregivers. You feel like you’re…
Everest to End Duchenne, an organization raising funds to support research to end Duchenne muscular dystrophy, is looking…